GLP-1 drugs were originally developed to treat type 2 diabetes.
Drugmakers are discovering the injections may also aid weight loss, heart issues, and sleep apnea.
AdvertisementAnother new indication for injectable GLP-1 drugs: better sleep.
On Wednesday, drugmaker Eli Lilly announced positive results from a large, phase-3 clinical trial, testing Zepbound (the drug name for tirzepatide) as a treatment for sleep apnea.
Related storyAlready, GLP-1 drugs have been indicated for the treatment of:ObesityHeart diseaseAdvertisementIn clinical trials, GLP-1 drugs have also shown some promise for treating other conditions, including:Non-alcoholic fatty liver diseaseAddictionDepressionParkinson's and Alzheimer'sCancerThese breakthroughs may be tied to the gut-brain connectionScientists think that the main reason GLP-1 drugs work well is because of their effect on our body's gut-brain connection.
Persons:
—, drugmaker Eli Lilly, Eli Lilly, KATERYNA, Daniel Drucker, GLP, Eric Topol
Organizations:
Service, Food and Drug Administration, American Diabetes Association, University of Toronto